Innovating
Wound Care

A first-of-its-kind formula designed to be powerful, gentle, and safe.

FDA Cleared –
Doctor Approved

While originally intended for OTC first aid use as an alternative to topical antibiotics, Hexagen’s performance in the chronic wound care market led to a shift in focus. Turn Therapeutics, the parent company, filed for and received FDA 510(K) clearance in 2016 for indications in chronic wound care. The FDA cleared range of use was/is broad, including the management of diabetic ulcers, burns, trauma wounds, and more. Healthcare professionals across the nation responded with overwhelming positive feedback on the efficacy of Hexagen for their patients without side effects.

The Hexagen Advantage

  • Non-irritating, non-sensitizing, non-cytotoxic
  • Petrolatum base won’t dry up or macerate wounds like hydrogels
  • Petrolatum base protects wounds, as well as prevents dressing adherence and subsequent wound disruption
  • Wide spectrum of effectiveness against known pathogens